Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000652878 | SCV000774750 | likely benign | Neuropathy, hereditary motor and sensory, type 6B | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001531604 | SCV001746819 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | SLC25A46: BS2 |
Gene |
RCV001531604 | SCV001796620 | uncertain significance | not provided | 2023-04-12 | criteria provided, single submitter | clinical testing | Observed with another variant in one individual with Parkinson disease; however, it is unknown whether these variants are on the same (in cis) or opposite (in trans) chromosomes (Liu et al., 2022); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: Liu_2022[Preprint]) |
Ambry Genetics | RCV002458148 | SCV002735741 | likely benign | Inborn genetic diseases | 2019-09-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mayo Clinic Laboratories, |
RCV001531604 | SCV004227107 | uncertain significance | not provided | 2022-02-03 | criteria provided, single submitter | clinical testing | BP4 |